Roberto Stasi
Department of Haematology
St. George's Hospital
London
UK
Name/email consistency: high
- Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care. Stasi, R., Murali, M., Michel, M., Viallard, J.F., Giagounidis, A., Janssens, A., Legg, J., Deuson, R., Danese, M.D. Int. J. Hematol. (2012)
- Therapeutic strategies for hepatitis- and other infection-related immune thrombocytopenias. Stasi, R. Semin. Hematol. (2009)
- Management of immune thrombocytopenic purpura in adults. Stasi, R., Provan, D. Mayo Clin. Proc. (2004)
- Cancer-related fatigue: evolving concepts in evaluation and treatment. Stasi, R., Abriani, L., Beccaglia, P., Terzoli, E., Amadori, S. Cancer (2003)
- Infliximab chimaeric anti-tumour necrosis factor alpha monoclonal antibody treatment for patients with myelodysplastic syndromes. Stasi, R., Amadori, S. Br. J. Haematol. (2002)
- The role of angiogenesis in hematologic malignancies. Stasi, R., Amadori, S. J. Hematother. Stem Cell Res. (2002)
- Sustained response to recombinant human erythropoietin and intermittent all-trans retinoic acid in patients with myelodysplastic syndromes. Stasi, R., Brunetti, M., Terzoli, E., Amadori, S. Blood (2002)